- Home
- Publications
- Publication Search
- Publication Details
Title
Ceftazidime dosing in obese patients: is it time for more?
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2022-05-18
DOI
10.1080/17425255.2022.2080052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units
- (2022) Elodie Matusik et al. BMC Nephrology
- Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
- (2021) Milo Gatti et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Association between obesity and urinary albumin-creatinine ratio in the middle-aged and elderly population of Southern and Northern China: a cross-sectional study
- (2021) Shan Qin et al. BMJ Open
- A sensitive and high‐throughput quantitative liquid chromatography high‐resolution mass spectrometry method for therapeutic drug monitoring of 10 β ‐lactam antibiotics, linezolid and two β ‐lactamase inhibitors in human plasma
- (2021) Sarah Van Vooren et al. BIOMEDICAL CHROMATOGRAPHY
- Effect of Obesity on Clinical Failure of Patients Treated with Beta-Lactams
- (2021) Nathan A Pinner et al. Open Forum Infectious Diseases
- Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity
- (2021) Anil R. Maharaj et al. PEDIATRIC DRUGS
- Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection
- (2021) Annabel Werumeus Buning et al. Antibiotics-Basel
- The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial
- (2020) A. Abdulla et al. BMC INFECTIOUS DISEASES
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
- (2020) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients
- (2020) Sebastiano Barco et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Leptin, Obesity, and Hypertension: A Review of Pathogenetic Mechanisms
- (2020) Song Chi Lu et al. Metabolic Syndrome and Related Disorders
- Using Therapeutic Drug Monitoring to Treat KPC-Producing Klebsiella pneumoniae Central Nervous System Infection With Ceftazidime/Avibactam
- (2020) Mohamad Yasmin et al. Open Forum Infectious Diseases
- Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients
- (2020) Marco Falcone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
- (2019) C. Lacroix et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa
- (2019) Pier Giorgio Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia
- (2019) Shampa Das et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Short communication
- (2019) Janni S. Mortensen et al. THERAPEUTIC DRUG MONITORING
- Steady‐State Ceftazidime‐Avibactam Serum Concentrations and Dosing Recommendations in a Critically Ill Patient Being Treated for Pseudomonas aeruginosa Pneumonia and Undergoing Continuous Venovenous Hemodiafiltration
- (2019) Paige Soukup et al. PHARMACOTHERAPY
- Simultaneous determination of eight β-lactam antibiotics in human plasma and cerebrospinal fluid by liquid chromatography coupled to tandem mass spectrometry
- (2019) Ronan Bellouard et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Representation of obese participants in obesity-related cancer randomized trials
- (2018) E Pestine et al. ANNALS OF ONCOLOGY
- Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
- (2018) Matt Shirley DRUGS
- Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
- (2018) Cornelis Smit et al. Expert Opinion on Drug Metabolism & Toxicology
- Beta-lactams in continuous infusion for Gram-negative bacilli osteoarticular infections: an easy method for clinical use
- (2018) Alba Ribera et al. INFECTION
- Obesity and Kidney Disease
- (2018) Jay I. Lakkis et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients
- (2018) Gary E. Stein et al. Surgical Infections
- Obesity and kidney disease: hidden consequences of the epidemic
- (2017) Csaba P. Kovesdy et al. INTERNAL MEDICINE JOURNAL
- Chronic Kidney Disease
- (2017) Angela C Webster et al. LANCET
- Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing
- (2017) Stephanie Natale et al. PHARMACOTHERAPY
- Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review
- (2016) Abdulaziz S. Alobaid et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
- (2016) Vivette D. D'Agati et al. Nature Reviews Nephrology
- Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-ProducingKlebsiella pneumoniaeBacteremia and Renal Impairment
- (2016) John J. Veillette et al. PHARMACOTHERAPY
- Drug Disposition in Obesity: Toward Evidence-Based Dosing
- (2015) Catherijne A.J. Knibbe et al. Annual Review of Pharmacology and Toxicology
- Lung Concentrations of Ceftazidime Administered by Continuous versus Intermittent Infusion in Patients with Ventilator-Associated Pneumonia
- (2015) Joël Cousson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Beyond BMI - Phenotyping the Obesities
- (2014) John E. Blundell et al. Obesity Facts
- Interaction of Obesity and Central Obesity on Elevated Urinary Albumin-to-Creatinine Ratio
- (2014) Nan Du et al. PLoS One
- Broad-spectrum β-lactams in obese non-critically ill patients
- (2014) M Hites et al. Nutrition & Diabetes
- Relationship between Acute Phase Proteins and Serum Fatty Acid Composition in Morbidly Obese Patients
- (2013) Ricardo Fernandes et al. DISEASE MARKERS
- Case-Control Study of Drug Monitoring of -Lactams in Obese Critically Ill Patients
- (2012) M. Hites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
- (2012) Margreke J.E. Brill et al. CLINICAL PHARMACOKINETICS
- Ceftazidime for respiratory infections
- (2012) Sang-Ho Choi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia
- (2012) A. E. Muller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Implications of Obesity for Drug Therapy: Limitations and Challenges
- (2011) R Jain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The effects of obesity on drug pharmacokinetics in humans
- (2011) Glynn A Morrish et al. Expert Opinion on Drug Metabolism & Toxicology
- The Effect of Obesity on Chronic Kidney Disease
- (2011) Joel D. Kopple et al. JOURNAL OF RENAL NUTRITION
- Appropriate Antibiotic Dosage Levels in the Treatment of Severe Sepsis and Septic Shock
- (2011) Fabio Silvio Taccone et al. Current Infectious Disease Reports
- High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant Pseudomonas Aeruginosa Infections in Immunocompromised Patients
- (2010) Brad Moriyama et al. ANNALS OF PHARMACOTHERAPY
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Estimation of creatinine clearance in morbidly obese patients
- (2009) Jasmina A. Demirovic et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Population Pharmacokinetics of Ceftazidime in Intensive Care Unit Patients: Influence of Glomerular Filtration Rate, Mechanical Ventilation, and Reason for Admission
- (2009) B. Georges et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- Nutritional Deficiencies in Bariatric Surgery Candidates
- (2009) Chaya Schweiger et al. OBESITY SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started